Merck KGaA Stock Deutsche Boerse AG

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 04:16:02 2024-04-19 am EDT 5-day change 1st Jan Change
145.4 EUR -1.02% Intraday chart for Merck KGaA -5.36% +1.53%
Sales 2024 * 21.25B 22.64B Sales 2025 * 22.5B 23.98B Capitalization 63.8B 67.98B
Net income 2024 * 2.97B 3.17B Net income 2025 * 3.48B 3.7B EV / Sales 2024 * 3.32 x
Net Debt 2024 * 6.79B 7.24B Net Debt 2025 * 4.83B 5.15B EV / Sales 2025 * 3.05 x
P/E ratio 2024 *
21.5 x
P/E ratio 2025 *
18.3 x
Employees 62,908
Yield 2024 *
1.57%
Yield 2025 *
1.65%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.11%
1 week-5.36%
Current month-10.65%
1 month-7.38%
3 months-0.48%
6 months-3.03%
Current year+1.53%
More quotes
1 week
143.90
Extreme 143.9
152.85
1 month
143.90
Extreme 143.9
164.60
Current year
140.50
Extreme 140.5
164.60
1 year
134.55
Extreme 134.55
172.15
3 years
134.55
Extreme 134.55
231.30
5 years
76.34
Extreme 76.34
231.30
10 years
57.50
Extreme 57.5
231.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 67 19-04-25
Director/Board Member 62 90-12-31
More insiders
Date Price Change Volume
24-04-19 145.6 -0.89% 0
24-04-18 146.8 0.00% 1,033
24-04-17 146.8 -3.23% 403
24-04-16 151.8 -0.72% 202
24-04-15 152.8 -0.62% 0

Delayed Quote Deutsche Boerse AG, April 19, 2024 at 02:20 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
146.8 EUR
Average target price
182 EUR
Spread / Average Target
+24.02%
Consensus